FDA approves class-wide opioids safety labeling updates
Added language intends to enable safer use of opioid pain medicines
Added language intends to enable safer use of opioid pain medicines
GeMDAC will advise on treatment safety and effectiveness
New medication for adults with this rare blood disorder
Event covers global clinical trials, bioequivalence and pharmacovigilance
Analysis shows switching is not associated with major safety events
Learn how the agency uses science and data to ensure drug safety, quality and efficacy
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.